GSK Consumer Healthcare on Friday said that it is expanding its portfolio with the launch of Iodex Rapid Action Spray.
With the new launch, Iodex now has an exhaustive portfolio of pain relief products - Iodex Balm, Iodex UltraGel & Iodex Rapid Action Spray, which can cater to different states of pain and address varied format preferences of consumers.
Also read: Sanofi-GSK get nod for Phase III trial of Covid vaccine candidate
Anurita Chopra, Area Marketing Lead, India sub-continent, GSK Consumer Healthcare said, “With the changing lifestyles of our consumers, the incidences of body pain have been on a rise. Therefore, as a brand that truly understands pain, we aim to be a one-stop solution that caters to every type of pain in any format .”
Iodex Rapid Action Spray is available in two packs- 35g at ₹140 and 60 g at ₹195 and is available across all leading chemist stores and e-commerce sites, the company added.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.